Outlook Wealth Advisors’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$276K Sell
1,247
-234
-16% -$51K 0.06% 269
2026
Q2
$289K Sell
1,481
-2,426
-62% -$503K 0.06% 259
2026
Q1
$877K Sell
3,907
-80
-2% -$19.9K 0.21% 100
2025
Q4
$960K Buy
3,987
+698
+21% +$179K 0.22% 90
2025
Q3
$900K Sell
3,289
-325
-9% -$88.8K 0.22% 97
2025
Q2
$933K Sell
3,614
-16
-0.4% -$3.82K 0.24% 82
2025
Q1
$813K Buy
3,630
+18
+0.5% +$4.2K 0.23% 86
2024
Q4
$826K Sell
3,612
-74
-2% -$17.8K 0.24% 87
2024
Q3
$900K Buy
3,686
+102
+3% +$22.8K 0.26% 76
2024
Q2
$686K Buy
+3,584
New +$727K 0.21% 95
2020
Q1
– Sell
-2,838
Closed -$440K – 179
2019
Q4
$440K Buy
2,838
+654
+30% +$94.3K 0.25% 74
2019
Q3
$295K Buy
+2,184
New +$286K 0.18% 135

Other funds holding RMD

Outlook Wealth Advisors's RMD Position: Q3 2026 in Review

Outlook Wealth Advisors reduced its ResMed (RMD) stake by 16% in Q3 2026, selling an estimated $51K and leaving 1,247 shares worth $276K. The position accounts for 0.06% of the portfolio, ranked #269.

Outlook Wealth Advisors first reported a position in RMD in Q3 2019 and has held it in 12 quarters since. The position peaked at $960K in Q4 2025. 886 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Outlook Wealth Advisors held 1,247 shares of ResMed worth $276K as of Q3 2026.
  • Outlook Wealth Advisors sold 234 ResMed shares in Q3 2026, an estimated $51K.
  • ResMed made up 0.06% of Outlook Wealth Advisors's portfolio in Q3 2026, its #269 holding.
  • Outlook Wealth Advisors first reported a position in ResMed in Q3 2019 and has held it in 12 quarters since.
  • Outlook Wealth Advisors's ResMed position peaked at $960K in Q4 2025.
  • 886 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Outlook Wealth Advisors's 13F filing for Q3 2026, filed 28 Oct 2026.